See also this year's filing and all EDGAR filings for this company.
PDF Report 0001614067_2023_Aridis_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001614067, Aridis Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 11,626,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 17,000 |
| 2 | PropertyPlantAndEquipmentNet | 730,000 |
| 3 | remainder_Assets | 2,322,000 |
| 4 | LiabilitiesCurrent | 36,898,000 |
| 5 | LiabilitiesNoncurrent | 5,528,000 |
| 6 | remainder_Liabilities | -3,499,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,161,000 |
| 9 | ResearchAndDevelopmentExpense | 25,923,000 |
| 10 | remainder_Expenses | 350,000 |
| 11 | remainder_Revenues | 3,184,000 |
| 12 | remainder_NetIncome | -121,000 |
| 13 | remainder_ComprehensiveNetIncome | 5,051,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 14,695,000 |
| 1 | Liabilities | 38,927,000 |
| 2 | Expenses | 33,434,000 |
| 3 | Revenues | 3,184,000 |
| 4 | StockholdersEquity | -24,232,000 |
| 5 | NetIncome | -30,371,000 |
| 6 | ComprehensiveNetIncome | -27,845,500 |
| 7 | BaseVar | 47,706,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.01 |
| 9 | EconomicCapitalRatio | 0.684 |
Edgar->Model Mapping
Feature Distribution
